SHINE Technologies Welcomes Healthcare and Defense Experts to Board
JANESVILLE, Wis., May 21, 2025 – SHINE Technologies, LLC, a leader in next-generation fusion technology with applications in industrial testing and medical isotopes, has announced significant appointments to its Board of Directors. Dr. Gregory Sorensen, a renowned healthcare technology leader, and Col. (Ret.) Gregory K. Van Dyk, a defense expert, join the company to enhance its strategic initiatives.
Dr. Sorensen, co-founder of DeepHealth and former President of Siemens Healthcare North America, brings extensive experience in healthcare technology and medical imaging to SHINE. His role will focus on guiding the company’s commercial strategy, fostering partnerships, and expanding its fusion-enabled medical isotope business. "SHINE represents the promise of fusion – not as a science experiment, but as a real-world solution," said Dr. Sorensen, expressing his eagerness to drive growth in new healthcare markets.
Meanwhile, Col. Van Dyk joins SHINE after a 22-year career in the U.S. Air Force, specializing in nuclear engineering and strategic deterrence. His experience includes leading the Department of Defense’s Fusion for National Security initiative, emphasizing the importance of fusion technology in national security. He will support SHINE’s FLARE program—a high-energy neutron testing service aimed at enhancing the resilience of defense technologies under extreme conditions. "FLARE offers a new capability for understanding how our most important defense technologies perform under the toughest conditions," stated Van Dyk.
Founded in Janesville, Wisconsin, SHINE is advancing sustainable energy solutions through its innovative fusion-based technologies, contributing to healthcare, national security, and environmental responsibility. With its focus on practical applications of fusion technology, SHINE aims to revolutionize energy production and various essential health services.
Source
Photo credit www.prnewswire.com
